Literature DB >> 8695364

'Tumour volume' as a predictor of survival after resection of non-small-cell lung cancer (NSCLC)

M F Jefferson1, N Pendleton, E B Faragher, G R Dixon, M W Myskow, M A Horan.   

Abstract

Many factors have been individually related to outcome in populations of non-small-cell lung cancer (NSCLC) patients. Factors responsible for the outcome of an individual after surgical resection are poorly understood. We have examined the importance of 'tumour volume' in determining prognosis of patients following resection of NSCLC in a multivariate model. Cox's proportional hazard analysis was used to determine the relative prognostic significance of stage, patient age, gender, tumour cell-type, nodal score and estimated 'tumour volume' in 669 cases with NSCLC treated with surgical resection, of which 280 had died. All factors (except tumour cell-type, P = 0.33) were individually related to survival (P < 0.05). When examined together, survival time was significantly and independently related to 'tumour volume' and stage (P < 0.001), and other factors ceased to be significant. In cases with stage I or II tumours, risk of death was found to increase significantly with increasing estimated 'tumour volume' (23.8% relative increase in hazard to death per doubling of 'tumour volume', 95% confidence interval 13.2-35.2%, P < 0.001 stage I; P < 0.006 stage II). In cases with stage IIIa tumours this factor alone was the significant prognostic variable. In conclusion, an estimate of 'tumour volume' significantly improves prediction of prognosis for individual NSCLC patients with UICC stage I or II tumours.

Entities:  

Mesh:

Year:  1996        PMID: 8695364      PMCID: PMC2074647          DOI: 10.1038/bjc.1996.381

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  National survey of the pattern of care for carcinoma of the lung.

Authors:  E W Humphrey; C R Smart; D P Winchester; G D Steele; J W Yarbro; K C Chu; H H Triolo
Journal:  J Thorac Cardiovasc Surg       Date:  1990-12       Impact factor: 5.209

2.  Tumor cell type versus staging in the prognosis of carcinoma of the lung.

Authors:  S D Greenberg; A E Fraire; B M Kinner; E H Johnson
Journal:  Pathol Annu       Date:  1987

3.  Lung carcinoma in the elderly population. Influence of histology on the inverse relationship of stage to age.

Authors:  S M Teeter; F F Holmes; M J McFarlane
Journal:  Cancer       Date:  1987-09-15       Impact factor: 6.860

4.  The use of biomarkers in the prediction of survival in patients with pulmonary carcinoma.

Authors:  W Walop; M Chrétien; N C Colman; R S Fraser; F Gilbert; R S Hidvegi; T Hutchinson; B Kelly; M Lis; W O Spitzer
Journal:  Cancer       Date:  1990-05-01       Impact factor: 6.860

5.  Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.

Authors:  K S Albain; J J Crowley; M LeBlanc; R B Livingston
Journal:  J Clin Oncol       Date:  1990-09       Impact factor: 44.544

6.  Surgical treatment of lung cancer.

Authors:  N Martini
Journal:  Semin Oncol       Date:  1990-08       Impact factor: 4.929

7.  Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis.

Authors:  J S Gronowitz; R Bergström; E Nôu; S Påhlman; O Brodin; S Nilsson; C F Källander
Journal:  Cancer       Date:  1990-08-15       Impact factor: 6.860

8.  Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly.

Authors:  M A O'Rourke; J R Feussner; P Feigl; J Laszlo
Journal:  JAMA       Date:  1987-08-21       Impact factor: 56.272

9.  Correlates of tumor size, gender, cell type, and metastasis of resected non-small cell lung cancer and age.

Authors:  N Pendleton; M F Jefferson; G R Dixon; M W Myskow; M A Horan
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1996-01       Impact factor: 6.053

10.  Prognostic factors for survival in patients with inoperable lung cancer.

Authors:  K E Stanley
Journal:  J Natl Cancer Inst       Date:  1980-07       Impact factor: 13.506

View more
  7 in total

1.  Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer.

Authors:  K Ichiki; N Mitani; Y Doki; H Hara; T Misaki; I Saiki
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer.

Authors:  R Baillie; J Carlile; N Pendleton; A M Schor
Journal:  J Clin Pathol       Date:  2001-02       Impact factor: 3.411

3.  Solitary lung tumors and their spontaneous metastasis in athymic nude mice orthotopically implanted with human non-small cell lung cancer.

Authors:  T Yamaura; K Murakami; Y Doki; S Sugiyama; T Misaki; Y Yamada; I Saiki
Journal:  Neoplasia       Date:  2000 Jul-Aug       Impact factor: 5.715

4.  'Tumour volume'.

Authors:  C A Clelland
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Relationship between vascularity, age and survival in non-small-cell lung cancer.

Authors:  L M Chandrachud; N Pendleton; D M Chisholm; M A Horan; A M Schor
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice.

Authors:  Y Doki; K Murakami; T Yamaura; S Sugiyama; T Misaki; I Saiki
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

7.  Prognostic significance of combined radiologic imaging modalities for prognosis of clinical IA adenocarcinomas.

Authors:  Hiroaki Kuroda; Shnsuke Mori; Hirotaka Tanaka; Tatsuya Yoshida; Tetsuya Mizuno; Noriaki Sakakura; Yasushi Yatabe; Hiroshi Iwata; Yukinori Sakao
Journal:  Oncotarget       Date:  2017-12-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.